Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 428 Enz. Inhib. hit(s) with all data for entry = 819
TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293258(US10106501, Example DO | US10106501, Example DT)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293259(US10106501, Example DP)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293209(US10106501, Example CJ | US10106501, Example DQ)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292883(US10106501, Example DR | US10106501, Example R)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292869(US10106501, Example DS | US10106501, Example J)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293258(US10106501, Example DO | US10106501, Example DT)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292884(US10106501, Example S)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292886(US10106501, Example U)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292887(US10106501, Example V)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292893(US10106501, Example AA)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292894(US10106501, Example AA-1)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292895(US10106501, Example AA-2)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292896(US10106501, Example AA-3)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292897(US10106501, Example AA-4)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293020(US10106501, Example AA-7)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293021(US10106501, Example AA-8)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293024(US10106501, Example AA-11)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293030(US10106501, Example AA-17)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293031(US10106501, Example AA-18)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293040(US10106501, Example AA-27)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293041(US10106501, Example AA-28)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293042(US10106501, Example AA-29)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293043(US10106501, Example AA-30)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293044(US10106501, Example AA-31)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293046(US10106501, Example AA-35)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293047(US10106501, Example AA-36)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293048(US10106501, Example AA-37)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293062(US10106501, Example AI1 | cis-4-(2,4-dichloro-3-((...)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293067(US10106501, Example AL | US10106501, Example AL1)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293073(US10106501, Example AN)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293075(US10106501, Example AN-2)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293076(US10106501, Example AN-3)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293077(US10106501, Example AN-4)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293078(US10106501, Example AN-5)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293079(US10106501, Example AO)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293080(US10106501, Example AP)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293081(US10106501, Example AP-1)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293082(US10106501, Example AQ)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293083(US10106501, Example AQ-1)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293090(US10106501, Example AW)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293091(US10106501, Example AX)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293092(US10106501, Example AY)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293093(US10106501, Example AZ)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293094(US10106501, Example BA)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293100(US10106501, Example BF-1)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293106(US10106501, Example BH)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293116(US10106501, Example BJ-8)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293118(US10106501, Example BJ-10)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293120(US10106501, Example BJ-12)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM293125(US10106501, Example BJ-17)
Affinity DataIC50: <100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Displayed 1 to 50 (of 428 total ) | Next | Last >>
Jump to: